Drug Type Peptide drug conjugates |
Synonyms |
Target |
Mechanism GnRHR modulators(Gonadotropin-releasing hormone receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Cancer | Preclinical | CN | 01 Jan 2025 | |
Triple Negative Breast Cancer | Preclinical | CN | 01 Jan 2025 |